SCHEMBL21062052

SCHEMBL21062052

O=S1(=O)CC(Nc2nc(Cl)nc3c2[S+]([O-])CC3)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30785572 0.87 GLP1R (0.32) —
SCHEMBL15976749 0.85 KMT2A (0.33) —
SCHEMBL22734115 0.82 KMT2A (0.38) —
SCHEMBL22734104 0.82 KMT2A (0.40) —
SCHEMBL22734105 0.81 KMT2A (0.43) —
SCHEMBL22734110 0.81 — —
SCHEMBL31491308 0.80 — —
SCHEMBL20840622 0.79 MAPK1 (0.35) —
SCHEMBL20851935 0.79 MAPK1 (0.35) —
SCHEMBL31474619 0.79 ADORA3 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3724194-B1 SUBSTITUTED AZETIDINE DIHYDROTHIENOPYRIMIDINES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS UNION THERAPEUTICS AS (DK) 2023-12-27 — — EP disclosed
CN-111712502-B Substituted azetidine dihydro-thienopyrimidines and their use as phosphodiesterase inhibitors 联合疗法公司 2023-10-27 — — CN disclosed
US-11292799-B2 Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors UNION therapeutics A/S (DK) 2022-04-05 — — US disclosed
US-20210070769-A1 SUBSTITUTED AZETIDINE DIHYDROTHIENOPYRIMIDINES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS UNION therapeutics A/S (DK) 2021-03-11 — — US disclosed
US-20210070769-A1 SUBSTITUTED AZETIDINE DIHYDROTHIENOPYRIMIDINES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS UNION therapeutics A/S (DK) 2021-03-11 — — US disclosed
EP-3724194-A1 SUBSTITUTED AZETIDINE DIHYDROTHIENOPYRIMIDINES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS Leo Pharma A/S (DK) 2020-10-21 — — EP disclosed
CN-111712502-A Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors 利奥制药有限公司 2020-09-25 — — CN disclosed
WO-2019115774-A1 SUBSTITUTED AZETIDINE DIHYDROTHIENOPYRIMIDINES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS LEO PHARMA A/S (DK) 2019-06-20 — — WO disclosed
Send feedback